In the latest session, Tempest Therapeutics Inc (NASDAQ: TPST) closed at $3.74 down -3.36% from its previous closing price of $3.87. In other words, the price has decreased by -$0.1300 from its previous closing price. On the day, 749877 shares were traded.
Ratios:
For a deeper understanding of Tempest Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.66 and its Current Ratio is at 1.66.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Scotiabank on March 14, 2024, initiated with a Sector Outperform rating and assigned the stock a target price of $13.
On February 08, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $15.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TPST now has a Market Capitalization of 74.49M and an Enterprise Value of 84.38M.
Stock Price History:
The Beta on a monthly basis for TPST is -1.73, which has changed by 184.63% over the last 52 weeks, in comparison to a change of 31.54% over the same period for the S&P500. Over the past 52 weeks, TPST has reached a high of $9.77, while it has fallen to a 52-week low of $0.17. The 50-Day Moving Average of the stock is 3.8766, while the 200-Day Moving Average is calculated to be 2.5660.
Shares Statistics:
For the past three months, TPST has traded an average of 793.31K shares per day and 680.03k over the past ten days. A total of 19.25M shares are outstanding, with a floating share count of 15.99M. Insiders hold about 16.90% of the company’s shares, while institutions hold 9.26% stake in the company. Shares short for TPST as of Feb 29, 2024 were 716.53k with a Short Ratio of 0.90, compared to 759.87k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 3.72% and a Short% of Float of 4.85%.
Earnings Estimates
There are 5 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.39 for the current quarter, with a high estimate of -$0.32 and a low estimate of -$0.43, while EPS last year was -$0.63. The consensus estimate for the next quarter is -$0.37, with high estimates of -$0.26 and low estimates of -$0.55.
Analysts are recommending an EPS of between -$1.83 and -$2 for the fiscal current year, implying an average EPS of -$1.93. EPS for the following year is -$1.44, with 6 analysts recommending between -$0.83 and -$2.07.
